MedPage Today

FDA Approves First Oral Helicase Inhibitor for Treatment-Resistant Herpes in Immunocompromised Patients

(MedPage Today) -- The FDA approved pritelivir (Hovilpri) tablets to treat mucocutaneous lesions caused by herpes simplex virus (HSV) infections in immunocompromised patients who haven't responded to other treatments. Pritelivir, an oral helicase...